Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:04 pm Purchase | 2024-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Austin Che | 2,372,573 5.000% | 2,372,573 (New Position) | Filing History |
| 2025-02-14 4:03 pm Purchase | 2025-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Reshma P. Shetty | 4,716,084 9.500% | 4,716,084 (New Position) | Filing History |
| 2025-01-30 9:58 pm Sale | 2024-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VANGUARD GROUP INC | 2,013,548 4.450% | -592,205 (-22.73%) | Filing History |
| 2025-01-10 9:25 pm Unchanged | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | ARK Investment Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.300% | 3,577,128 (New Position) | Filing History |
| 2024-11-12 3:58 pm Unchanged | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VANGUARD GROUP INC | 2,605,753 6.040% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:56 am Purchase | 2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VANGUARD GROUP INC | 2,605,753 6.040% | 2,605,753 (New Position) | Filing History |
| 2024-07-05 10:29 am Purchase | 2024-06-28 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | BAILLIE GIFFORD & CO | 3,360,647 7.870% | 3,360,647 (New Position) | Filing History |
| 2024-02-14 5:08 pm Sale | 2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Knight Thomas F. Jr. | 1,708,211 4.100% | -165,192 (-8.82%) | Filing History |
| 2024-02-14 5:06 pm Sale | 2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Austin Che | 2,397,462 5.600% | -98,970 (-3.96%) | Filing History |
| 2024-02-14 5:05 pm Sale | 2024-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Reshma P. Shetty | 4,716,098 10.500% | -178,615 (-3.65%) | Filing History |
| 2024-02-14 5:03 pm Sale | 2024-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA | Kelly Jason R | 2,143,808 5.000% | -281,628 (-11.61%) | Filing History |
| 2024-02-14 10:16 am Unchanged | 2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.800% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VANGUARD GROUP INC | 3,319,492 8.200% | 781,460 (+30.79%) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | ARK Investment Management LLC | 4,965,165 12.260% | 1,355,564 (+37.55%) | Filing History |
| 2024-01-29 09:55 am Sale | 2023-12-29 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | BAILLIE GIFFORD & CO | 5,907,305 14.590% | -197,112 (-3.23%) | Filing History |
| 2023-02-14 5:02 pm Purchase | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Austin Che | 2,496,432 6.300% | 423,410 (+20.42%) | Filing History |
| 2023-02-14 5:01 pm Sale | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Knight Thomas F. Jr. | 1,873,403 5.000% | -3,673 (-0.20%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 9.360% | 700,025 (+24.33%) | Filing History |
| 2023-02-14 12:00 pm Purchase | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Anchorage Capital Group L.L.C. | 1,747,615 4.830% | 17,406 (+1.01%) | Filing History |